CLINICAL TRIALS PROFILE FOR CISATRACURIUM BESYLATE
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
All Clinical Trials for Cisatracurium Besylate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02508857 ↗ | Magnesium Sulfate Improves Postoperative Analgesia in Laparoscopic Gynecologic Surgeries | Completed | Instituto do Cancer do Estado de São Paulo | Phase 4 | 2010-01-01 | Magnesium sulfate has been reported to improve postoperative pain, but evidence is still controversial. Some studies demonstrated benefits while others concluded that there is no efficacy. Aim: the aim of the study was to compare the effect of intravenous infusion of magnesium sulfate to ketorolac during laparoscopic gynecologic oncology surgeries. Methods: We designed a double-blind randomized controlled trial that compared intravenous magnesium sulfate to ketorolac and saline solution in postoperative pain, morphine consumption and opioid related side effects. |
NCT02509078 ↗ | Reevaluation Of Systemic Early Neuromuscular Blockade | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 2016-01-04 | This study evaluates whether giving a neuromuscular blocker (skeletal muscle relaxant) to a patient with acute respiratory distress syndrome will improve survival. Half of the patients will receive a neuromuscular blocker for two days and in the other half the use of neuromuscular blockers will be discouraged. |
NCT02509078 ↗ | Reevaluation Of Systemic Early Neuromuscular Blockade | Completed | Massachusetts General Hospital | Phase 3 | 2016-01-04 | This study evaluates whether giving a neuromuscular blocker (skeletal muscle relaxant) to a patient with acute respiratory distress syndrome will improve survival. Half of the patients will receive a neuromuscular blocker for two days and in the other half the use of neuromuscular blockers will be discouraged. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Cisatracurium Besylate
Condition Name
Clinical Trial Locations for Cisatracurium Besylate
Trials by Country
Clinical Trial Progress for Cisatracurium Besylate
Clinical Trial Phase
Clinical Trial Sponsors for Cisatracurium Besylate
Sponsor Name
Sponsor Name for Cisatracurium Besylate | |
Sponsor | Trials |
Second Affiliated Hospital of Nanchang University | 4 |
General Hospital of Ningxia Medical University | 2 |
National Heart, Lung, and Blood Institute (NHLBI) | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |